Fulcrum Therapeutics, Inc. (FULC)

NASDAQ: FULC · Real-Time Price · USD

3.590

-0.140 (-3.75%)

At close: Jul 9, 2026, 4:00 PM EDT

3.570

-0.020 (-0.56%)

After-hours: Jul 9, 2026, 4:32 PM EDT

Fulcrum Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	50.26	197.53	58.21	25.56	35.1	35.41
Short-Term Investments	283.06	154.77	182.81	210.66	167.82	182.75
Cash & Short-Term Investments	333.32	352.31	241.02	236.22	202.92	218.16
Cash Growth	47.09%	46.17%	2.03%	16.41%	-6.99%	93.21%
Accounts Receivable	-	-	2.1	0.54	0.23	3.64
Other Current Assets	5.35	5.17	6.81	5.44	4.37	4.2
Total Current Assets	338.67	357.48	249.92	242.2	207.52	226
Net Property, Plant & Equipment	6.35	7.07	9.58	12.39	15.97	7.37
Other Long-Term Assets	1.75	1.74	1.21	3.1	3.2	1.63
Total Assets	346.77	366.28	260.72	257.69	226.69	235
Accounts Payable	2.45	1.59	1.16	2.76	3.64	4.79
Accrued Expenses	4.95	9.05	7.69	8.73	9.55	9.23
Current Portion of Leases	2.46	2.4	2.19	2.19	2.6	-
Unearned Revenue	-	-	-	-	0.93	4.71
Other Current Liabilities	-	-	-	-	-	0.47
Total Current Liabilities	9.86	13.05	11.04	13.68	16.73	19.2
Long-Term Leases	3.41	4.04	6.44	8.63	10.82	-
Other Long-Term Liabilities	0.2	0.2	0.2	0.2	0.2	4.26
Total Long-Term Liabilities	3.6	4.24	6.64	8.83	11.02	4.26
Total Liabilities	13.47	17.28	17.68	22.5	27.74	23.46
Common Stock	0.07	0.07	0.05	0.06	0.05	0.04
Additional Paid-in Capital	946.92	943.04	762.25	744.94	612.03	514.36
Accumulated Other Comprehensive Income	-0.51	0.17	0.13	-0.14	-0.8	-0.4
Retained Earnings	-613.17	-594.28	-519.4	-509.67	-412.34	-302.47
Shareholders' Equity	333.3	349	243.03	235.19	198.94	211.54
Total Liabilities & Equity	346.77	366.28	260.72	257.69	226.69	235
Total Debt	5.87	6.44	8.63	10.82	13.42	0
Net Cash (Debt)	327.45	345.86	232.39	225.4	189.5	218.16
Net Cash Growth	-5.32%	48.83%	3.10%	18.95%	-13.14%	93.21%
Net Cash Per Share	4.90	5.46	3.75	3.68	4.21	6.17
Book Value	333.3	349	243.03	235.19	198.94	211.54
Book Value Per Share	4.99	5.51	3.92	3.84	4.42	5.98
Tangible Book Value	333.3	349	243.03	235.19	198.94	211.54
Tangible Book Value Per Share	4.99	5.51	3.92	3.84	4.42	5.98

SEC Filings: 10-K · 10-Q